Concepedia

Huifang Dong

HD

8

Publications

931

Citations

8

H-Index

1999

Active since

Affiliations

Science Applications International Corporation (United States)(Current)

Center for Cancer Research

National Cancer Institute

Cancer Genetics (United States)

Huifang Dong is an author at Science Applications International Corporation (United States) specializing in medicine, pharmacology, and drug discovery.

ORCID

Top concepts

Publications per year

1999–2018

8

Publications

8

Thioredoxin, a Redox Enzyme Released in Infection and Inflammation, Is a Unique Chemoattractant for Neutrophils, Monocytes, and T Cells

Riccardo Bertini, O. M. Zack Howard, Huifang Dong et al. · The Journal of Experimental Medicine · 1999 · 339 citations · Full text

Chemotactic Activity of S100A7 (Psoriasin) Is Mediated by the Receptor for Advanced Glycation End Products and Potentiates Inflammation with Highly Homologous but Functionally Distinct S100A15

Ronald Wolf, O. M. Zack Howard, Huifang Dong et al. · The Journal of Immunology · 2008 · 167 citations · Full text

Genetically Encoded Azide Containing Amino Acid in Mammalian Cells Enables Site-Specific Antibody–Drug Conjugates Using Click Cycloaddition Chemistry

Michael Pete VanBrunt, Kurt Shanebeck, Zachary Caldwell et al. · Bioconjugate Chemistry · 2015 · 137 citations

, , +15

T follicular helper–like cells contribute to skin fibrosis

Devon K. Taylor, Nanette Mittereder, Ellen Kuta et al. · Science Translational Medicine · 2018 · 102 citations

Tannic acid is an inhibitor of CXCL12 (SDF-1alpha)/CXCR4 with antiangiogenic activity.

Xin Chen, John A. Beutler, Thomas G. McCloud et al. · PubMed · 2003 · 86 citations

Rows per page

1–5 of 8